Joint Basis for FDA/HHS Marijuana Rescheduling Recommendation Unveiled
The FDA Law Blog
JANUARY 18, 2024
FDA conducted the eight-factor scheduling analysis required by the CSA in 2016 and found that marijuana continued to meet the scheduling criteria for remaining in schedule I. 12, 2016); Denial of Petition to Initiate Proceedings to Reschedule Marijuana, 81 Fed. Denial of Petition to Initiate Proceedings to Reschedule Marijuana, 81 Fed.
Let's personalize your content